Pre-clinical and clinical applications of small interfering RNAs (siRNA) and co-delivery systems for pancreatic cancer therapy

S Mirzaei, MH Gholami, HL Ang, F Hashemi, A Zarrabi… - Cells, 2021 - mdpi.com
Pancreatic cancer (PC) is one of the leading causes of death and is the fourth most
malignant tumor in men. The epigenetic and genetic alterations appear to be responsible for …

miRacle of microRNA-driven cancer nanotherapeutics

G Kara, B Arun, GA Calin, B Ozpolat - Cancers, 2022 - mdpi.com
Simple Summary The discovery of microRNAs has revolutionized the world of science and
opened up new opportunities in cancer treatment. miRNA dysregulation plays a crucial role …

Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery

O Taratula, OB Garbuzenko, P Kirkpatrick… - Journal of Controlled …, 2009 - Elsevier
Low penetration ability of Small Interfering RNA (siRNA) through the cellular plasma
membrane combined with its limited stability in blood, limits the effectiveness of the systemic …

Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems

S Mirzaei, MK Mahabady, A Zabolian, A Abbaspour… - Life Sciences, 2021 - Elsevier
Glioblastoma multiforme (GBM) is one of the worst brain tumors arising from glial cells,
causing many deaths annually. Surgery, chemotherapy, radiotherapy and immunotherapy …

Delivery of therapeutic miRNA using polymer-based formulation

E Ban, TH Kwon, A Kim - Drug delivery and translational research, 2019 - Springer
MicroRNAs (miRNAs) are short non-coding RNAs that play important roles in many cellular
processes such as development, proliferation, differentiation, and apoptosis. For this reason …

Oral delivery of RNAi for cancer therapy

H Afrin, R Geetha Bai, R Kumar, SS Ahmad… - Cancer and Metastasis …, 2023 - Springer
Cancer is a major health concern worldwide and is still in a continuous surge of seeking for
effective treatments. Since the discovery of RNAi and their mechanism of action, it has …

Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA

SD Li, S Chono, L Huang - Molecular Therapy, 2008 - cell.com
The selective delivery of small interfering RNA (siRNA) to metastatic tumors remains a
challenging task. We have developed a nanoparticle (NP) formulation composed of siRNA …

Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities

Z Wang, G Liu, H Zheng, X Chen - Biotechnology advances, 2014 - Elsevier
Gene therapy is a promising strategy to treat various genetic and acquired diseases. Small
interfering RNA (siRNA) is a revolutionary tool for gene therapy and the analysis of gene …

miRNA nanotherapeutics for cancer

A Ganju, S Khan, BB Hafeez, SW Behrman… - Drug discovery today, 2017 - Elsevier
Highlights•MicroRNAs play a major role in cancer.•Several clinical trials with microRNA are
reported for cancer treatment.•Delivery of microRNA encounters several challenges.•We …

Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer

M Ashrafizadeh, K Hushmandi, E Rahmani Moghadam… - Bioengineering, 2020 - mdpi.com
Prostate cancer (PCa) accounts for a high number of deaths in males with no available
curative treatments. Patients with PCa are commonly diagnosed in advanced stages due to …